Illinois Oncology Research Association Community Clinical Oncology Program

伊利诺伊州肿瘤研究协会的长期目标 位于伊利诺伊州皮奥里亚的社区临床肿瘤学项目（IORA CCOP）基本保持不变， 它继续在社区环境中工作，以加快制定干预措施， 预防、治疗、康复和治愈癌症。具体而言，IORA CCOP寻求扩大 在伊利诺斯州中部和西部的社区进行癌症临床试验;促进优质护理 通过参与和采用临床研究试验的结果，在整个社区; 促进科学上可行的社区癌症网络的持续发展，与NCI合作- 赞助合作小组试验;通过健康教育促进癌症预防、控制和治疗 向医护人员及公众宣传预防癌症、及早发现及适当治疗的重要性 以及让初级保健医生和其他癌症预防专家参与进来 尽可能进行试验;增加已知和新的癌症治疗的知识基础;并鼓励 让少数群体和得不到充分服务的人群参与癌症临床试验和相关研究。 IORA CCOP及其附属机构在18个县的集水区提供癌症临床试验。 该地区跨越超过12，000平方英里的农村地区，但大多数患者都很容易在一个 距离IORA CCOP在16个社区的25个组成部分/附属机构之一的一小时车程。虽然6个 在皮奥里亚本身的分支机构，IORA CCOP医疗肿瘤学家前往所有15个社区以外 皮奥里亚每周一次，所有社区都得到该地区附属辐射设施的支持。 IORA CCOP使用直接来自北中央癌症中心的最先进的研究方案。 治疗组（NCCTG）、美国东部肿瘤协作组（ECOG）、癌症和白血病组B （CALGB）、国家外科辅助乳腺和肠道项目（NSABP）和放射治疗肿瘤学 通过临床试验支持单位（CTSU）与其他研究小组间接合作 在美国和加拿大。IORA CCOP与这些组织建立了良好的工作关系， 组其集中的记录保存和质量控制系统，多年的临床试验经验， 其工作人员的专业知识，CCOP肿瘤团队的承诺，以及 研究患者倡导者都有助于在社区中进行持续的高质量研究 设定并导致患者受益和记录结果。 相关性（见说明）：随着美国的不断发展，癌症继续对生活产生重大影响。 公民的权利。由于大多数癌症患者在其家庭社区接受治疗， 癌症患者及其家人的公共健康，在当地提供高质量的癌症护理。癌 临床试验提供了最好的癌症预防，治疗和症状管理， 临床肿瘤学计划是使这些最好的治疗方法在世界上可用的理想机制。 因此对所有癌症患者的治疗产生积极影响，即使是那些 不参加临床试验。

The long-term objectives of the Illinois Oncology Research Association Community Clinical Oncology Program (IORA CCOP), based in Peoria, IL, remain essentially unchanged as it continues to work within a community setting to accelerate the development of interventions for preventing, treating, recovering from and curing cancer. Specifically, the IORA CCOP seeks to expand accrual to cancer clinical trials in the communities of central and western Illinois; stimulate quality care throughout the community through participation in and adoption of results from clinical research trials; promote the continued growth of a scientifically viable community cancer network to work with NCI- sponsored cooperative group trials; promote cancer prevention, control, and treatment by educating health care professionals and the public on the importance of cancer prevention, early detection, proper treatment and continuing care and by involving primary care physicians and other specialists in cancer prevention trials whenever possible; add to the knowledge base of known and new cancer treatments; and encourage the involvement of minority and underserved populations in cancer clinical trials and associated research. The IORA CCOP and its affiliates offer access to cancer clinical trials in an 18-county catchment area. This area spans more than 12,000 square miles of mostly rural country, yet most patients are easily within a one hour drive of one of the IORA CCOP's 25 components/affiliates in 16 communities. Although 6 of the affiliates are in Peoria itself, the IORA CCOP medical oncologists travel to all 15 communities outside Peoria weekly and all communities are supported by the affiliated radiation facilities in the region. The IORA CCOP uses state-of-the-art research protocols directly from the North Central Cancer Treatment Group (NCCTG), Eastern Cooperative Oncology Group (ECOG), Cancer and Leukemia Group B (CALGB), National Surgical Adjuvant Breast and Bowel Project (NSABP), and Radiation Therapy Oncology Group (RTOG), and indirectly, through the Clinical Trials Support Unit (CTSU), with other research groups in the United States and Canada. The IORA CCOP enjoys excellent working relationships with these groups. Its centralized record keeping and quality control systems, its years of clinical trials experience, the expertise of its staff, the commitment of the CCOP oncology team, and the active involvement of the research patient advocates all lend themselves to continued quality research conducted in a community setting and resulting in patient benefit and documented results. RELEVANCE (See instructions): As the U.S. DODulation apes, cancer continues to have a maior impact on the lives of its citizens. Since most cancer patients are treated in their home communities, it is critically important to the public health of cancer patients and their families that quality cancer care be available locally. Cancer clinical trials offer the best in cancer prevention, treatment and symptom management, and the Community Clinical Oncology Program is the ideal mechanism for making these best treatments available in the community and consequently having a positive impact on the treatments of all cancer patients, even those not participating in a clinical trial.